Study of TCM Syndrome of Hepatocellular Carcinoma and Colorectal Cancer Based on System Science
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Traditional Chinese medicine (TCM) syndrome is a core foundation of disease knowledge,
clinical diagnosis and treatment and curative effect evaluation in TCM. "Same TCM Syndrome
for Different Diseases" and "Same Treatment for Different Diseases" is one of the
characteristics of TCM syndrome differentiation and treatment.
This study is the "TCM disease syndrome combination" research baced on principles and methods
of system biology, which is through acquisition of primary hepatocellular carcinoma (HCC) and
colorectal cancer patients with TCM syndrome information, detection of clinical indicators
and genomic, proteomic, and metabolites changes, analyzing the correlation between TCM
syndromes and biological information, and revealing its biological material characteristics
and the molecular mechanisms of "Same TCM Syndrome for Different Diseases";Developing and
implementing the program of TCM syndrome differentiation and treatment for HCC and colorectal
cancer to evaluate the efficacy of TCM syndrome based-treatment of HCC and colorectal cancer
with TCM syndrom scores, clinical and systems biological indicators, quality of life and
survival rate, and to revealing the mechanism of the "Same Treatment for Different Diseases".
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine